Comorbidities like hypertension, DM, and coronary heart disease (CHD) may affect myocardial fibrosis and remodeling, potentially causing inaccuracies in Gal-3 serum level measurements. The gene discussed is LGALS3; the disease is Myocardial fibrosis.